Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-influenza Drugs Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Oseltamivir
1.2.3 Zanamivir
1.2.4 Peramivir
1.2.5 Other
1.3 Market by Application
1.3.1 Global Anti-influenza Drugs Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Children
1.3.3 Adults
1.3.4 Elderly
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Anti-influenza Drugs Market Perspective (2018-2033)
2.2 Anti-influenza Drugs Growth Trends by Region
2.2.1 Global Anti-influenza Drugs Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Anti-influenza Drugs Historic Market Size by Region (2018-2023)
2.2.3 Anti-influenza Drugs Forecasted Market Size by Region (2024-2033)
2.3 Anti-influenza Drugs Market Dynamics
2.3.1 Anti-influenza Drugs Industry Trends
2.3.2 Anti-influenza Drugs Market Drivers
2.3.3 Anti-influenza Drugs Market Challenges
2.3.4 Anti-influenza Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anti-influenza Drugs Players by Revenue
3.1.1 Global Top Anti-influenza Drugs Players by Revenue (2018-2023)
3.1.2 Global Anti-influenza Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Anti-influenza Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Anti-influenza Drugs Revenue
3.4 Global Anti-influenza Drugs Market Concentration Ratio
3.4.1 Global Anti-influenza Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-influenza Drugs Revenue in 2022
3.5 Anti-influenza Drugs Key Players Head office and Area Served
3.6 Key Players Anti-influenza Drugs Product Solution and Service
3.7 Date of Enter into Anti-influenza Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Anti-influenza Drugs Breakdown Data by Type
4.1 Global Anti-influenza Drugs Historic Market Size by Type (2018-2023)
4.2 Global Anti-influenza Drugs Forecasted Market Size by Type (2024-2033)
5 Anti-influenza Drugs Breakdown Data by Application
5.1 Global Anti-influenza Drugs Historic Market Size by Application (2018-2023)
5.2 Global Anti-influenza Drugs Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Anti-influenza Drugs Market Size (2018-2033)
6.2 North America Anti-influenza Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Anti-influenza Drugs Market Size by Country (2018-2023)
6.4 North America Anti-influenza Drugs Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Anti-influenza Drugs Market Size (2018-2033)
7.2 Europe Anti-influenza Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Anti-influenza Drugs Market Size by Country (2018-2023)
7.4 Europe Anti-influenza Drugs Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Anti-influenza Drugs Market Size (2018-2033)
8.2 Asia-Pacific Anti-influenza Drugs Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Anti-influenza Drugs Market Size by Region (2018-2023)
8.4 Asia-Pacific Anti-influenza Drugs Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Anti-influenza Drugs Market Size (2018-2033)
9.2 Latin America Anti-influenza Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Anti-influenza Drugs Market Size by Country (2018-2023)
9.4 Latin America Anti-influenza Drugs Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anti-influenza Drugs Market Size (2018-2033)
10.2 Middle East & Africa Anti-influenza Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Anti-influenza Drugs Market Size by Country (2018-2023)
10.4 Middle East & Africa Anti-influenza Drugs Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Detail
11.1.2 Roche Business Overview
11.1.3 Roche Anti-influenza Drugs Introduction
11.1.4 Roche Revenue in Anti-influenza Drugs Business (2018-2023)
11.1.5 Roche Recent Development
11.2 HEC Pharm
11.2.1 HEC Pharm Company Detail
11.2.2 HEC Pharm Business Overview
11.2.3 HEC Pharm Anti-influenza Drugs Introduction
11.2.4 HEC Pharm Revenue in Anti-influenza Drugs Business (2018-2023)
11.2.5 HEC Pharm Recent Development
11.3 Shanghai Zhongxisanwei
11.3.1 Shanghai Zhongxisanwei Company Detail
11.3.2 Shanghai Zhongxisanwei Business Overview
11.3.3 Shanghai Zhongxisanwei Anti-influenza Drugs Introduction
11.3.4 Shanghai Zhongxisanwei Revenue in Anti-influenza Drugs Business (2018-2023)
11.3.5 Shanghai Zhongxisanwei Recent Development
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Detail
11.4.2 GlaxoSmithKline Business Overview
11.4.3 GlaxoSmithKline Anti-influenza Drugs Introduction
11.4.4 GlaxoSmithKline Revenue in Anti-influenza Drugs Business (2018-2023)
11.4.5 GlaxoSmithKline Recent Development
11.5 Guangzhou Pharmaceutical
11.5.1 Guangzhou Pharmaceutical Company Detail
11.5.2 Guangzhou Pharmaceutical Business Overview
11.5.3 Guangzhou Pharmaceutical Anti-influenza Drugs Introduction
11.5.4 Guangzhou Pharmaceutical Revenue in Anti-influenza Drugs Business (2018-2023)
11.5.5 Guangzhou Pharmaceutical Recent Development
11.6 Hunan Nucien Pharmaceutical
11.6.1 Hunan Nucien Pharmaceutical Company Detail
11.6.2 Hunan Nucien Pharmaceutical Business Overview
11.6.3 Hunan Nucien Pharmaceutical Anti-influenza Drugs Introduction
11.6.4 Hunan Nucien Pharmaceutical Revenue in Anti-influenza Drugs Business (2018-2023)
11.6.5 Hunan Nucien Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Anti-influenza Drugs Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Oseltamivir
Table 3. Key Players of Zanamivir
Table 4. Key Players of Peramivir
Table 5. Key Players of Other
Table 6. Global Anti-influenza Drugs Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Anti-influenza Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Anti-influenza Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Anti-influenza Drugs Market Share by Region (2018-2023)
Table 10. Global Anti-influenza Drugs Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Anti-influenza Drugs Market Share by Region (2024-2033)
Table 12. Anti-influenza Drugs Market Trends
Table 13. Anti-influenza Drugs Market Drivers
Table 14. Anti-influenza Drugs Market Challenges
Table 15. Anti-influenza Drugs Market Restraints
Table 16. Global Anti-influenza Drugs Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Anti-influenza Drugs Market Share by Players (2018-2023)
Table 18. Global Top Anti-influenza Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-influenza Drugs as of 2022)
Table 19. Ranking of Global Top Anti-influenza Drugs Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Anti-influenza Drugs Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Anti-influenza Drugs Product Solution and Service
Table 23. Date of Enter into Anti-influenza Drugs Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Anti-influenza Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Anti-influenza Drugs Revenue Market Share by Type (2018-2023)
Table 27. Global Anti-influenza Drugs Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Anti-influenza Drugs Revenue Market Share by Type (2024-2033)
Table 29. Global Anti-influenza Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Anti-influenza Drugs Revenue Market Share by Application (2018-2023)
Table 31. Global Anti-influenza Drugs Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Anti-influenza Drugs Revenue Market Share by Application (2024-2033)
Table 33. North America Anti-influenza Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 34. North America Anti-influenza Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Anti-influenza Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 36. Europe Anti-influenza Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. Europe Anti-influenza Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Anti-influenza Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 39. Asia-Pacific Anti-influenza Drugs Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 40. Asia-Pacific Anti-influenza Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Anti-influenza Drugs Market Size by Region (2024-2033) & (US$ Million)
Table 42. Latin America Anti-influenza Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Latin America Anti-influenza Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Anti-influenza Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 45. Middle East & Africa Anti-influenza Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Middle East & Africa Anti-influenza Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Anti-influenza Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 48. Roche Company Detail
Table 49. Roche Business Overview
Table 50. Roche Anti-influenza Drugs Product
Table 51. Roche Revenue in Anti-influenza Drugs Business (2018-2023) & (US$ Million)
Table 52. Roche Recent Development
Table 53. HEC Pharm Company Detail
Table 54. HEC Pharm Business Overview
Table 55. HEC Pharm Anti-influenza Drugs Product
Table 56. HEC Pharm Revenue in Anti-influenza Drugs Business (2018-2023) & (US$ Million)
Table 57. HEC Pharm Recent Development
Table 58. Shanghai Zhongxisanwei Company Detail
Table 59. Shanghai Zhongxisanwei Business Overview
Table 60. Shanghai Zhongxisanwei Anti-influenza Drugs Product
Table 61. Shanghai Zhongxisanwei Revenue in Anti-influenza Drugs Business (2018-2023) & (US$ Million)
Table 62. Shanghai Zhongxisanwei Recent Development
Table 63. GlaxoSmithKline Company Detail
Table 64. GlaxoSmithKline Business Overview
Table 65. GlaxoSmithKline Anti-influenza Drugs Product
Table 66. GlaxoSmithKline Revenue in Anti-influenza Drugs Business (2018-2023) & (US$ Million)
Table 67. GlaxoSmithKline Recent Development
Table 68. Guangzhou Pharmaceutical Company Detail
Table 69. Guangzhou Pharmaceutical Business Overview
Table 70. Guangzhou Pharmaceutical Anti-influenza Drugs Product
Table 71. Guangzhou Pharmaceutical Revenue in Anti-influenza Drugs Business (2018-2023) & (US$ Million)
Table 72. Guangzhou Pharmaceutical Recent Development
Table 73. Hunan Nucien Pharmaceutical Company Detail
Table 74. Hunan Nucien Pharmaceutical Business Overview
Table 75. Hunan Nucien Pharmaceutical Anti-influenza Drugs Product
Table 76. Hunan Nucien Pharmaceutical Revenue in Anti-influenza Drugs Business (2018-2023) & (US$ Million)
Table 77. Hunan Nucien Pharmaceutical Recent Development
Table 78. Research Programs/Design for This Report
Table 79. Key Data Information from Secondary Sources
Table 80. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anti-influenza Drugs Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Anti-influenza Drugs Market Share by Type: 2022 VS 2033
Figure 3. Oseltamivir Features
Figure 4. Zanamivir Features
Figure 5. Peramivir Features
Figure 6. Other Features
Figure 7. Global Anti-influenza Drugs Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 8. Global Anti-influenza Drugs Market Share by Application: 2022 VS 2033
Figure 9. Children Case Studies
Figure 10. Adults Case Studies
Figure 11. Elderly Case Studies
Figure 12. Anti-influenza Drugs Report Years Considered
Figure 13. Global Anti-influenza Drugs Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global Anti-influenza Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global Anti-influenza Drugs Market Share by Region: 2022 VS 2033
Figure 16. Global Anti-influenza Drugs Market Share by Players in 2022
Figure 17. Global Top Anti-influenza Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-influenza Drugs as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Anti-influenza Drugs Revenue in 2022
Figure 19. North America Anti-influenza Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America Anti-influenza Drugs Market Share by Country (2018-2033)
Figure 21. United States Anti-influenza Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Anti-influenza Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Anti-influenza Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Anti-influenza Drugs Market Share by Country (2018-2033)
Figure 25. Germany Anti-influenza Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. France Anti-influenza Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. U.K. Anti-influenza Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Italy Anti-influenza Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Russia Anti-influenza Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Nordic Countries Anti-influenza Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Anti-influenza Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Anti-influenza Drugs Market Share by Region (2018-2033)
Figure 33. China Anti-influenza Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Japan Anti-influenza Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. South Korea Anti-influenza Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Southeast Asia Anti-influenza Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. India Anti-influenza Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Australia Anti-influenza Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Anti-influenza Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Anti-influenza Drugs Market Share by Country (2018-2033)
Figure 41. Mexico Anti-influenza Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Brazil Anti-influenza Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Anti-influenza Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Anti-influenza Drugs Market Share by Country (2018-2033)
Figure 45. Turkey Anti-influenza Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Saudi Arabia Anti-influenza Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Roche Revenue Growth Rate in Anti-influenza Drugs Business (2018-2023)
Figure 48. HEC Pharm Revenue Growth Rate in Anti-influenza Drugs Business (2018-2023)
Figure 49. Shanghai Zhongxisanwei Revenue Growth Rate in Anti-influenza Drugs Business (2018-2023)
Figure 50. GlaxoSmithKline Revenue Growth Rate in Anti-influenza Drugs Business (2018-2023)
Figure 51. Guangzhou Pharmaceutical Revenue Growth Rate in Anti-influenza Drugs Business (2018-2023)
Figure 52. Hunan Nucien Pharmaceutical Revenue Growth Rate in Anti-influenza Drugs Business (2018-2023)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed